Bliss GVS Pharma Limited

BLISSGVS

Quarterly results

Revenue and net profit

₹ crore

Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.

  • Income
  • ₹ crore

    Sept 2026261

    Quarter₹ croreYoY
    Sept 2024183+6.6%
    Dec 2024180+11.3%
    Mar 2025156-4.8%
    Jun 2025163+9.7%
    Sept 2025190+4.1%
    Dec 2025165-8.3%
    Mar 2026212+35.6%
    Jun 2026222+35.6%
    Sept 2026261+37.3%
  • ₹ crore

    Sept 20267

    Quarter₹ crore
    Sept 20248
    Dec 202412
    Mar 20259
    Jun 202511
    Sept 202526
    Dec 202510
    Mar 20269
    Jun 20269
    Sept 20267
  • ₹ crore

    Sept 2026269

    Quarter₹ crore
    Sept 2024191
    Dec 2024191
    Mar 2025165
    Jun 2025174
    Sept 2025216
    Dec 2025175
    Mar 2026221
    Jun 2026230
    Sept 2026269
  • Cost structure
  • ₹ crore

    Sept 202638

    Quarter₹ crore
    Sept 202424
    Dec 202426
    Mar 202525
    Jun 202528
    Sept 202530
    Dec 202532
    Mar 202632
    Jun 202637
    Sept 202638
  • ₹ crore

    Sept 2026211

    Quarter₹ crore
    Sept 2024167
    Dec 2024161
    Mar 2025151
    Jun 2025143
    Sept 2025183
    Dec 2025147
    Mar 2026177
    Jun 2026179
    Sept 2026211
  • Exceptional items and tax
  • ₹ crore

    Sept 202698

    Quarter₹ crore
    Sept 202424
    Dec 202430
    Mar 202514
    Jun 202531
    Sept 202533
    Dec 202525
    Mar 202644
    Jun 202651
    Sept 202698
  • ₹ crore

    Sept 202625

    Quarter₹ crore
    Sept 20247
    Dec 20249
    Mar 20253
    Jun 202510
    Sept 20259
    Dec 20257
    Mar 202612
    Jun 202613
    Sept 202625
  • Profit
  • ₹ crore

    Sept 202674

    Quarter₹ croreYoY
    Sept 202417-49.7%
    Dec 202421+1.6%
    Mar 202511+199.9%*
    Jun 202521+8.4%
    Sept 202525+45.5%
    Dec 202519-11.6%
    Mar 202632+183.1%
    Jun 202639+83.4%
    Sept 202674+196.7%
  • Per share
  • ₹ per share

    Sept 20266.93

    Quarter₹ per share
    Sept 20241.63
    Dec 20242.00
    Mar 20251.08
    Jun 20252.00
    Sept 20252.35
    Dec 20251.76
    Mar 20263.06
    Jun 20263.65
    Sept 20266.93
  • Leverage
  • Debt to equity

    times

    Jun 20250.00x

    Quartertimes
    Sept 20240.00x
    Dec 20240.00x
    Mar 20250.00x
    Jun 20250.00x
    Sept 2025—
    Dec 2025—
    Mar 2026—
    Jun 2026—
    Sept 2026—
₹ croreSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026Sept 2026
Income
183180156163190165212222261
Revenue YoY+6.6%+11.3%-4.8%+9.7%+4.1%-8.3%+35.6%+35.6%+37.3%
8129112610997
191191165174216175221230269
Cost structure
242625283032323738
167161151143183147177179211
Exceptional items and tax
243014313325445198
7931097121325
Profit
172111212519323974
Net profit YoY-49.7%+1.6%+199.9%*+8.4%+45.5%-11.6%+183.1%+83.4%+196.7%
Per share
1.632.001.082.002.351.763.063.656.93
Leverage
Debt to equity0.00x0.00x0.00x0.00x—————

Latest filed period ends Sept 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 9 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.

VValue Huddle

Indian company filings, read properly. Ownership, results and pledges.

The data

  • 2,914 companies
  • Screener built 16 Nov 2026
  • No share prices, by design

Figures may contain errors of transcription or of the filing itself. Nothing here is investment advice, a recommendation, or a share price. Companies revise their filings; where we hold a revision, the revised figure is the one shown.